Additionally, the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity trial demonstrated that semaglutide consistently reduced major cardiovascular event endpoints by approximately 20% compared to placebo over an approximately 3-year follow-up period in patients with overweight or obesity and cardiovascular disease (Table 1), but without diabetes [93]
The tirzepatide breast milk study: newer data, similar findings Tirzepatide data emerged more recently, and the findings mirror what researchers found with semaglutide
View Study [5]"Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris" Lu Z, Liu N, et al., 2023 Finding: Purified LR3 IGF-1 displayed excellent bioactivity for cell proliferation comparable to standard IGF-1, confirming that the molecular modifications preserve its biological function while extending its active lifespan
Product Details 8689415912812 Specific References Note Reviews(2)
Sempica supplies retatrutide to a 99.8% purity standard, verified by independent third-party Certificate of Analysis
Porter, K., L
